Researchers in Spain have developed a device that simulates the improved vision that a cataract patient can have before corrective surgery even takes place.
The scientists at the Spanish National Research Council’s Institute of Optics in Madrid compared the visual acuity obtained at different distances through a commercial trifocal lens (with focal points for close, intermediate and long focal distances), through the same lens simulated by a spatial light modulator, and through SimVis, a technology they developed that contains an optotunable lens working in a temporal multiplexing mode.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.